PMID- 30300655 OWN - NLM STAT- MEDLINE DCOM- 20181214 LR - 20211204 IS - 1879-0631 (Electronic) IS - 0024-3205 (Linking) VI - 212 DP - 2018 Nov 1 TI - Effect of valproic acid alone or combined with low dose gamma irradiation in modulating PTZ-induced convulsions in rats involving AKT/m-TOR pathway. PG - 261-266 LID - S0024-3205(18)30624-6 [pii] LID - 10.1016/j.lfs.2018.10.007 [doi] AB - AIM: The current study evaluates the anticonvulsant effect of valproic acid (VPA) alone or combined with low dose gamma-irradiation (LDR) against pentylenetetrazol-induced convulsions in rats. MATERIAL AND METHODS: Five groups of rats were used, group I served as normal control, group II served as PTZ- control and the other three groups were pretreated with single LDR(o.5 Gy), VPA(150 mg/kg i.p.5 days) and VPA with LDR respectively before PTZ injection. Racine score, latency and duration of convulsions were assessed. Evaluation of brain neurotransmitters (glutamate and GABA) as well as AKT/m-TOR pathway (protein kinase B [AKT], mammalian target of rapamycin [m-TOR], protein S6 and caspase 3). Measurement of oxidative stress (Malondialdehyde, glutathione and nitric oxide) was carried out. Histopathological examinations of hippocampi were done. KEY FINDINGS: PTZ resulted in behavioural changes (high Racine score, long seizure duration and short latency).PTZ enhanced oxidative stress state (high MDA and NO, as well as low GSH) compared to normal control. VPA alone or combined with LDR ameliorated, the convulsions and caused significant improvement in behavioural changes and other tested parameters compared to normal control. Histopathological examination of hippocampi was carried out to adjoin the biochemical changes. Certain changes were observed after PTZ injection. However, normal pictures of the other tested groups. SIGNIFICANCE: The previously mentioned findings support that LDR purveyed novel anticonvulsant activity which could offer a possible contributor in the basic treatment of convulsions. This effect might be due to modulation of AkT/m-TOR pathway, reduction of oxidative stress and modulation of neurotransmitters. CI - Copyright (c) 2018 Elsevier Inc. All rights reserved. FAU - Lotfy, Dina M AU - Lotfy DM AD - Department of drug radiation research, National Centre for Radiation Research and Technology, Atomic Energy Authority, Cairo, Egypt. Electronic address: pharmadinaa@yahoo.com. FAU - Safar, Marwa M AU - Safar MM AD - Department of pharmacology and toxicology, faculty of pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt; Department of Pharmacology and Biochemistry, The British University in Egypt, Suez Desert Road, P.O. Box 43, El Sherouk City, Cairo 11837, Egypt. FAU - Mohamed, Seham H AU - Mohamed SH AD - Department of drug radiation research, National Centre for Radiation Research and Technology, Atomic Energy Authority, Cairo, Egypt. FAU - Kenawy, Sanaa A AU - Kenawy SA AD - Department of pharmacology and toxicology, faculty of pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt. LA - eng PT - Journal Article DEP - 20181006 PL - Netherlands TA - Life Sci JT - Life sciences JID - 0375521 RN - 0 (Anticonvulsants) RN - 0 (Convulsants) RN - 614OI1Z5WI (Valproic Acid) RN - EC 2.7.1.1 (mTOR protein, rat) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - WM5Z385K7T (Pentylenetetrazole) SB - IM MH - Animals MH - Anticonvulsants/*pharmacology MH - Convulsants/toxicity MH - *Gamma Rays MH - Gene Expression Regulation/drug effects/radiation effects MH - Male MH - Pentylenetetrazole/*toxicity MH - Proto-Oncogene Proteins c-akt/*metabolism MH - Rats MH - Rats, Wistar MH - Seizures/chemically induced/metabolism/*therapy MH - TOR Serine-Threonine Kinases/*metabolism MH - Valproic Acid/*pharmacology OTO - NOTNLM OT - Brain neurotransmitters OT - Convulsions OT - Low dose gamma irradiation OT - Pentylenetetrazole OT - Rapamycin OT - Valproic acid EDAT- 2018/10/10 06:00 MHDA- 2018/12/15 06:00 CRDT- 2018/10/10 06:00 PHST- 2018/08/17 00:00 [received] PHST- 2018/09/29 00:00 [revised] PHST- 2018/10/05 00:00 [accepted] PHST- 2018/10/10 06:00 [pubmed] PHST- 2018/12/15 06:00 [medline] PHST- 2018/10/10 06:00 [entrez] AID - S0024-3205(18)30624-6 [pii] AID - 10.1016/j.lfs.2018.10.007 [doi] PST - ppublish SO - Life Sci. 2018 Nov 1;212:261-266. doi: 10.1016/j.lfs.2018.10.007. Epub 2018 Oct 6.